نتایج جستجو برای: cb2

تعداد نتایج: 2089  

2001
Stuart R. Stone

From the $Department of Hwmatology, University of Cambridge, MRC Centre, Hills Road, Cambridge CB2 2QH, the MFRC ~OratOOrY of Molecular signalling, Department of Zoology, University of Cambridge, Downing Street, Cambridge CB2 3EJ, t h ((Department Of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 lQJ, and t h **Rheumatology Research unit, Addenbrooke’s Hospital, Hills R...

2015
Alena V. Savonenko Tatiana Melnikova Yuchuan Wang Hayden Ravert Yongjun Gao Jeremy Koppel Deidre Lee Olga Pletnikova Eugenia Cho Nuzhat Sayyida Andrew Hiatt Juan Troncoso Peter Davies Robert F. Dannals Martin G. Pomper Andrew G. Horti Joseph El Khoury

In Alzheimer's disease (AD), one of the early responses to Aβ amyloidosis is recruitment of microglia to areas of new plaque. Microglial receptors such as cannabinoid receptor 2 (CB2) might be a suitable target for development of PET radiotracers that could serve as imaging biomarkers of Aβ-induced neuroinflammation. Mouse models of amyloidosis (J20APPswe/ind and APPswe/PS1ΔE9) were used to inv...

Journal: :The Journal of clinical endocrinology and metabolism 2016
Francesca Rossi Giulia Bellini Livio Luongo Iolanda Manzo Salvatore Tolone Chiara Tortora Maria Ester Bernardo Anna Grandone Antonella Conforti Ludovico Docimo Bruno Nobili Laura Perrone Franco Locatelli Sabatino Maione Emanuele Miraglia Del Giudice

CONTEXT Obesity is associated with a low-grade inflammatory state and adipocyte (ADP) hyperplasia/hypertrophy. Obesity inhibits the "browning" of white adipose tissue. Cannabinoid receptor 2 (CB2) agonists reduce food intake and induce antiobesity effect in mice. A common missense CB2 variant, Q63R, causes CB2-reduced function. OBJECTIVE To evaluate the influence of CB2 receptor on the modula...

2014
G. Cristina Brailoiu Elena Deliu Jahan Marcu Nicholas E. Hoffman Linda Console-Bram Pingwei Zhao Muniswamy Madesh Mary E. Abood Eugen Brailoiu

The therapeutic and psychoactive properties of cannabinoids have long been recognized. The type 2 receptor for cannabinoids (CB2) has emerged as an important therapeutic target in several pathologies, as it mediates beneficial effects of cannabinoids while having little if any psychotropic activity. Difficulties associated with the development of CB2-based therapeutic agents have been related t...

Journal: :Journal of the National Cancer Institute 2015
Eduardo Pérez-Gómez Clara Andradas Sandra Blasco-Benito María M Caffarel Elena García-Taboada María Villa-Morales Estefanía Moreno Sigrid Hamann Ester Martín-Villar Juana M Flores Antonia Wenners Ibrahim Alkatout Wolfram Klapper Christoph Röcken Peter Bronsert Elmar Stickeler Annette Staebler Maret Bauer Norbert Arnold Joaquim Soriano Manuel Pérez-Martínez Diego Megías Gema Moreno-Bueno Silvia Ortega-Gutiérrez Marta Artola Henar Vázquez-Villa Miguel Quintanilla José Fernández-Piqueras Enric I Canela Peter J McCormick Manuel Guzmán Cristina Sánchez

BACKGROUND Pharmacological activation of cannabinoid receptors elicits antitumoral responses in different cancer models. However, the biological role of these receptors in tumor physio-pathology is still unknown. METHODS We analyzed CB2 cannabinoid receptor protein expression in two series of 166 and 483 breast tumor samples operated in the University Hospitals of Kiel, Tübingen, and Freiburg...

2016
Yong Li Jimok Kim

Neurocognitive effects of cannabinoids have been extensively studied with a focus on CB1 cannabinoid receptors because CB1 receptors have been considered the major cannabinoid receptor in the nervous system. However, recent discoveries of CB2 cannabinoid receptors in the brain demand accurate determination of whether and how CB2 receptors are involved in the cognitive effects of cannabinoids. C...

2016
Timothé Denaës Jasper Lodder Marie-Noële Chobert Isaac Ruiz Jean-Michel Pawlotsky Sophie Lotersztajn Fatima Teixeira-Clerc

Kupffer cells, the resident macrophages of the liver, play a major role in the pathogenesis of alcoholic liver disease. We have previously demonstrated that CB2 receptor protects against alcoholic liver disease by inhibiting alcohol-induced inflammation and steatosis via the regulation of Kupffer cell activation. Here, we explored the mechanism underlying these effects and hypothesized that the...

2012
Thomas Rühl Winnie Deuther-Conrad Steffen Fischer Robert Günther Lothar Hennig Harald Krautscheid Peter Brust

BACKGROUND The endocannabinoid system is involved in many physiological and pathological processes. Two receptors (cannabinoid receptor type 1 (CB1) and type 2 (CB2)) are known so far. Many unwanted psychotic side effects of inhibitors of this system can be addressed to the interaction with CB1. While CB1 is one of the most abundant neuroreceptors, CB2 is expressed in the brain only at very low...

Journal: :Molecular pharmacology 2007
Fang He Zhuan-Hong Qiao Jian Cai William Pierce Da-Cheng He Zhao-Hui Song

The endocannabinoid 2-arachidonoylglycerol (2-AG) enhances cell migration through the CB2 cannabinoid receptor. In this study, using an immunoprecipitation and mass spectrometry-based proteomic approach, we first identified the 90-kDa heat shock protein (Hsp90), a chaperone protein with novel signaling functions, as a CB2-interacting protein. The CB2/Hsp90 interaction was confirmed in human emb...

Journal: :Hepatology 2010
Fatima Teixeira-Clerc Marie-Pierre Belot Sylvie Manin Vanessa Deveaux Thomas Cadoudal Marie-Noele Chobert Alexandre Louvet Andreas Zimmer Thierry Tordjmann Ariane Mallat Sophie Lotersztajn

UNLABELLED The cannabinoid receptor 2 (CB2) plays a pleiotropic role in innate immunity and is a crucial mediator of liver disease. In this study, we investigated the impact of CB2 receptors on the regenerative process associated with liver injury. Following acute hepatitis induced by carbon tetrachloride (CCl(4)), CB2 was induced in the nonparenchymal cell fraction and remained undetectable in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید